Stay updated on ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page.

Latest updates to the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study content or page layout.SummaryDifference0.1%

- Check3 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0, reflecting a version label update on the page; no study content or core functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedUI text updates include adding a Show glossary option, capitalization changes to labels such as 'Last Update Submitted that Met QC Criteria', and a new revision indicator (Revision: v3.4.0) replacing v3.3.4. These changes do not modify study content or data.SummaryDifference0.2%

- Check25 days agoChange DetectedMinor revision update from v3.3.3 to v3.3.4 is shown on the page, with no changes to study data, outcomes, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations were reorganized under a single 'Locations' header with state subsections for Arizona, California, Florida, Nevada, Texas, and Utah, replacing the prior separate 'Arizona Locations', 'California Locations', etc. This clarifies where the study is recruiting and makes site information easier for potential participants to use.SummaryDifference0.7%

- Check76 days agoChange DetectedThe Publications section now notes that items are automatically filled from PubMed and may not all pertain to the study, and the revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in NAFLD Diabetic & Non-Diabetic: Clinical Trial page.